Hailey Bieber Skin Compared to Similar Public Figures: What the Evidence Actually Shows

What Hailey Bieber Has Actually Disclosed About Her Skin

Hailey Bieber's public skin narrative centers on two pillars: a long-standing relationship with board-certified dermatologists and her own experience with perioral dermatitis. She has been more specific than most celebrities about the prescription medications she uses, making clinical comparison possible rather than purely speculative.

Prescription Tretinoin and Retinoid Use

Bieber confirmed in a 2022 YouTube video on her channel that she uses prescription tretinoin as part of her nighttime routine, applied under dermatologist guidance. Tretinoin (all-trans retinoic acid) remains the gold-standard topical retinoid for photoaging and acne prevention. A 48-week randomized controlled trial (N=204) published in the Journal of the American Academy of Dermatology demonstrated that tretinoin 0.025% cream produced statistically significant improvement in fine wrinkling, mottled hyperpigmentation, and surface roughness compared to vehicle [1]. The drug works by binding retinoic acid receptors (RARs), accelerating keratinocyte turnover, and stimulating dermal collagen synthesis [2].

What separates Bieber's disclosure from the vague "I use retinol" claims common among public figures is the specificity. She named the prescription form, not an over-the-counter retinol derivative. This distinction matters clinically. Tretinoin is 10 to 20 times more potent than retinol at receptor binding, according to pharmacokinetic data reviewed by the American Academy of Dermatology [3].

Perioral Dermatitis Diagnosis

In late 2022, Bieber posted unfiltered photos of perioral dermatitis flares on her skin, describing the condition as recurring and frustrating. Perioral dermatitis is a papulopustular eruption concentrated around the mouth, nasolabial folds, and sometimes the periorbital region. It affects approximately 0.5% to 1% of the population, with a strong female predominance (female-to-male ratio of roughly 12:1) [4].

Standard first-line treatment involves oral tetracyclines (doxycycline 40 mg modified-release or 100 mg daily) for 6 to 12 weeks, combined with withdrawal of topical corticosteroids if applicable [5]. Bieber has not publicly specified which oral antibiotic she was prescribed, but her dermatologist, Dr. Dhaval Bhanusali, confirmed in an interview with Allure that her treatment plan included "eliminating triggers and using targeted anti-inflammatory therapy." The American Academy of Dermatology's guidelines position topical metronidazole and oral doxycycline as the primary evidence-based interventions [5].

Rhode Skincare Philosophy as a Treatment Signal

Rhode, Bieber's skincare brand launched in 2022, offers indirect evidence of her treatment philosophy. The line is deliberately minimal: a peptide glazing fluid, a barrier restore cream, and a lip treatment. The peptide glazing fluid contains palmitoyl tripeptide-38, niacinamide, and squalane. This is not a cosmeceutical with aggressive actives. It reads as a barrier-supportive companion to prescription retinoid use, which commonly causes dryness and irritation during the adaptation period.

A 2019 systematic review in the British Journal of Dermatology (N=6,464 across 23 studies) found that ceramide-containing moisturizers significantly reduced transepidermal water loss (TEWL) and improved skin barrier function in patients using topical retinoids [6]. Rhode's formulations align with this clinical logic, even if marketed as standalone products to consumers.

Kendall Jenner: The Acne-to-Advocacy Pipeline

Kendall Jenner represents the most direct peer comparison to Bieber in terms of public skin disclosure. Jenner has spoken extensively about her history with hormonal and cystic acne, including a prominent 2019 Golden Globes appearance where she attended with visible breakouts and faced intense media commentary.

Proactiv Partnership and Its Clinical Limitations

Jenner's paid partnership with Proactiv in 2019 drew both attention and criticism. Proactiv's core active ingredient is benzoyl peroxide (BP) at 2.5% in its daily cleanser formulation. While BP is an established first-line acne treatment with strong evidence (a Cochrane review of 120 RCTs confirmed BP's superiority to placebo for mild-to-moderate acne) [7], the endorsement was criticized because Jenner later acknowledged that her acne improvement was primarily driven by prescription isotretinoin, not Proactiv.

This is a meaningful distinction for public health communication. Isotretinoin (13-cis-retinoic acid) produces complete or near-complete remission in 85% of patients after a single 16-to-24-week course at cumulative doses of 120 to 150 mg/kg [8]. Benzoyl peroxide, while effective for mild acne, does not produce the same durable remission in moderate-to-severe nodulocystic disease.

Hormonal Context

Jenner has also referenced hormonal contributions to her acne, aligning with clinical data showing that approximately 50% to 80% of adult female acne has a hormonal component driven by androgen-mediated sebaceous gland stimulation [9]. Unlike Bieber, Jenner has not publicly disclosed use of spironolactone or combined oral contraceptives for hormonal acne management, though these are standard second-line agents per the Endocrine Society's 2018 guidelines [10].

Kylie Jenner: Brand-First, Clinical Disclosure Second

Kylie Jenner's skin narrative is dominated by her Kylie Skin brand rather than any personal treatment disclosure. She has not publicly discussed prescription dermatologic medications, named specific conditions, or referenced dermatologist visits with the same specificity as Bieber or Kendall Jenner.

Product-Driven Versus Treatment-Driven Transparency

Kylie Skin's formulations (a foaming face wash with kiwi seed oil, a walnut face scrub, a vanilla moisturizer) lean toward cosmetic indulgence rather than evidence-based dermatology. The walnut scrub ingredient, in particular, was criticized by dermatologists for potentially causing microtears in the stratum corneum, a concern supported by data showing that irregular-shaped physical exfoliants can disrupt the skin barrier more than chemical exfoliants like glycolic acid [11].

The contrast with Bieber's approach is stark. Where Rhode's formulations track closely with dermatologic literature on barrier repair and peptide signaling, Kylie Skin's lineup reads as consumer-driven rather than clinician-informed. This is not a quality judgment but a transparency comparison. Bieber has disclosed her Rx regimen; Kylie Jenner has not.

Bella Hadid: Surgical Transparency and Skin Health

Bella Hadid introduced a different dimension to celebrity skin and appearance disclosure when she told Vogue in 2022 that she regretted having rhinoplasty at age 14 and denied having other facial procedures. Her public narrative focuses on structural and surgical decisions rather than topical or pharmaceutical skin treatments.

The Rhinoplasty Disclosure in Context

Hadid's disclosure is noteworthy because it represents one of the few instances where a top-tier model publicly confirmed a cosmetic procedure and expressed regret. The American Society of Plastic Surgeons reported 352,555 rhinoplasty procedures in 2020, making it the most common facial cosmetic surgery in the U.S. [12]. Performing rhinoplasty on a 14-year-old falls within a clinical gray zone. The ASPS and AAO-HNS guidelines recommend waiting until nasal growth is complete, typically age 15 to 16 in females and 17 to 18 in males [12].

Hadid has not discussed topical retinoid use, acne treatments, or any dermatologic prescriptions publicly. Her skin transparency stops at the structural level, making direct comparison to Bieber's pharmaceutical disclosures difficult.

Rosie Huntington-Whiteley: The Retinoid Peer

Among Bieber's broader peer group of models and beauty entrepreneurs, Rosie Huntington-Whiteley may be the closest parallel in terms of disclosed treatment approach. Huntington-Whiteley has discussed prescription retinoid use in multiple interviews, including a Harper's Bazaar feature where she described tretinoin as "the one thing that actually changed my skin."

Shared Retinoid Strategy, Different Brand Expression

Both Bieber and Huntington-Whiteley anchor their routines on prescription tretinoin, supported by barrier-repair moisturization. Huntington-Whiteley's brand, Rose Inc, uses a slightly different formulation philosophy (more pigment-focused, with a skin tint as its hero product), but the underlying clinical logic mirrors Rhode's: protect the barrier, let the Rx do the heavy lifting.

Dr. Ranella Hirsch, a board-certified dermatologist and former president of the American Society of Cosmetic Dermatology & Aesthetic Surgery, has noted: "The patients who get the best long-term results from retinoids are the ones who pair them with aggressive hydration and barrier support. The retinoid does the remodeling; the moisturizer keeps the skin tolerant enough to continue."

This philosophy is validated by a 2021 split-face RCT (N=40) in Dermatologic Therapy showing that patients who applied a ceramide-hyaluronic acid moisturizer with tretinoin 0.05% experienced 62% less retinoid dermatitis than the tretinoin-only side, with equivalent anti-aging efficacy at 24 weeks [13].

The "Glazed Donut" Trend in Clinical Context

Bieber popularized the "glazed donut skin" aesthetic, a high-shine, dewy look achieved through layered hydration. While this is primarily a cosmetic trend, it has clinical implications worth examining.

Hydration Layering and Transepidermal Water Loss

The glazed donut look involves applying humectants (hyaluronic acid, glycerin), followed by emollients (squalane, peptides), and sealed with an occlusive (a rich moisturizer or facial oil). This sequence mirrors the dermatologic principle of layered occlusion to reduce TEWL.

Measurements of TEWL in healthy volunteers show baseline values of 5 to 15 g/m²/h on the face [14]. Proper occlusive application can reduce TEWL by 40% to 60%, according to data published in the Journal of Investigative Dermatology [14]. For patients on tretinoin, whose TEWL is temporarily elevated due to increased keratinocyte turnover, this layering approach has direct therapeutic relevance.

Where Trend Meets Evidence

The risk of the glazed donut trend is comedogenicity. Heavy occlusive layering over acne-prone skin can worsen follicular occlusion. A 2020 study in Clinical and Experimental Dermatology found that patients with acne vulgaris who used heavy occlusives experienced a 23% increase in comedone counts over 8 weeks compared to gel-based moisturizer users [15]. Bieber's own perioral dermatitis history suggests her skin is reactive, and heavy occlusion around the perioral region could theoretically trigger flares.

The distinction matters: what works for Bieber's skin type (dry, retinoid-adapted, barrier-compromised) may not translate to an oily, acne-prone viewer following the same routine without prescription retinoid use.

How Celebrity Skin Disclosures Affect Patient Behavior

The clinical significance of these comparisons extends beyond gossip. A 2023 cross-sectional survey (N=1,012) published in JAMA Dermatology found that 42% of respondents aged 18 to 34 had purchased a skincare product based on a celebrity recommendation, and 17% had asked their dermatologist about a specific prescription after seeing a celebrity discuss it online [16].

The Disclosure Spectrum

Among the peer group examined here, the transparency gradient runs roughly as follows:

| Public Figure | Prescription Rx Disclosed | Condition Named | Brand Alignment with Rx | |---|---|---|---| | Hailey Bieber | Tretinoin (confirmed) | Perioral dermatitis | High (Rhode supports retinoid use) | | Kendall Jenner | Isotretinoin (confirmed post-hoc) | Cystic acne | Low (Proactiv partnership conflicted) | | Rosie Huntington-Whiteley | Tretinoin (confirmed) | None publicly | Moderate (Rose Inc is cosmetic-first) | | Bella Hadid | None disclosed | None dermatologic | N/A | | Kylie Jenner | None disclosed | None publicly | Low (Kylie Skin is consumer-driven) |

Bieber occupies the highest-disclosure position in this peer set. That does not make her approach medically superior, but it does make it more clinically evaluable.

What Dermatologists Recommend Patients Take Away

The American Academy of Dermatology's 2024 position statement on social media and dermatology emphasized that "celebrity endorsements of skincare products, when not accompanied by disclosure of concurrent prescription treatments, can create unrealistic expectations and delay appropriate medical care" [3]. Bieber's willingness to name tretinoin alongside her brand products partially addresses this concern, though her Rhode marketing does not reference prescription retinoids on packaging or promotional materials.

Patients comparing their skin to any public figure should understand that the visible outcome is a product of genetics, professional-grade treatments (lasers, peels, injectables), lighting and photography, and pharmaceutical interventions that may or may not be disclosed. A 2022 survey in the British Journal of Dermatology found that 78% of dermatologists reported patients presenting with "unrealistic expectations driven by filtered or professionally photographed celebrity skin images" [6].

The most actionable takeaway from Bieber's disclosed routine is the tretinoin-plus-barrier-support framework, which has decades of evidence behind it and costs as little as $15 to $45 per month with a generic tretinoin prescription and a basic ceramide moisturizer from any pharmacy.